Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/04/2789938/0/en/Kronos-Bio-Announces-Participation-in-H-C-Wainwright-4th-Annual-Precision-Oncology-Virtual-Conference.html

SAN MATEO, Calif. and CAMBRIDGE, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq:KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that Jorge DiMartino M.D., Ph.D., chief medical officer and executive vice president of clinical development, and Charles Lin, Ph.D., senior vice president of TRN mapping will participate in a fireside chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference on Wednesday, December 6, 2023 at 11:00 a.m. ET.

Read more at globenewswire.com

Related news for (KRON)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.